BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25701112)

  • 1. Does chronic infection in retroviruses have a sense?
    Barbeau B; Mesnard JM
    Trends Microbiol; 2015 Jun; 23(6):367-75. PubMed ID: 25701112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
    Ma G; Yasunaga JI; Shimura K; Takemoto K; Watanabe M; Amano M; Nakata H; Liu B; Zuo X; Matsuoka M
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HTLV-1 bZIP Factor (HBZ): Roles in HTLV-1 Oncogenesis].
    Wu W; Cheng W; Chen M; Xu L; Zhao T
    Bing Du Xue Bao; 2016 Mar; 32(2):235-42. PubMed ID: 27396170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?
    Miller RH; Zimmer A; Moutot G; Mesnard JM; Chazal N
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
    Mitobe Y; Yasunaga J; Furuta R; Matsuoka M
    Cancer Res; 2015 Oct; 75(19):4143-52. PubMed ID: 26383166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.
    Murphy J; Hall WW; Ratner L; Sheehy N
    Virology; 2016 Jul; 494():129-42. PubMed ID: 27110706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.
    Higuchi Y; Yasunaga JI; Mitagami Y; Tsukamoto H; Nakashima K; Ohshima K; Matsuoka M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13740-13749. PubMed ID: 32471947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
    Valeri VW; Hryniewicz A; Andresen V; Jones K; Fenizia C; Bialuk I; Chung HK; Fukumoto R; Parks RW; Ferrari MG; Nicot C; Cecchinato V; Ruscetti F; Franchini G
    Blood; 2010 Nov; 116(19):3809-17. PubMed ID: 20647569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of HBZ in HTLV-1-Induced Oncogenesis.
    Zhao T
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
    Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
    Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.
    Cavanagh MH; Landry S; Audet B; Arpin-André C; Hivin P; Paré ME; Thête J; Wattel E; Marriott SJ; Mesnard JM; Barbeau B
    Retrovirology; 2006 Mar; 3():15. PubMed ID: 16512901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and Pathogenic Roles of Retroviral Antisense Transcripts.
    Toyoda K; Matsuoka M
    Front Immunol; 2022; 13():875211. PubMed ID: 35572593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs).
    Barbeau B; Mesnard JM
    Viruses; 2011 May; 3(5):456-68. PubMed ID: 21994742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
    Matsuoka M
    Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular study of HBZ and gp21 human T cell leukemia virus type 1 proteins isolated from different clinical profile infected individuals.
    Mota-Miranda AC; Barreto FK; Baptista E; Farre-Vale L; Monteiro-Cunha JP; Galvão-Castro B; Alcantara LC
    AIDS Res Hum Retroviruses; 2013 Oct; 29(10):1370-2. PubMed ID: 23800288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virological aspects of HTLV-1 infection and new therapeutical concepts].
    Mahieux R
    Bull Soc Pathol Exot; 2011 Aug; 104(3):181-7. PubMed ID: 21607661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.
    Gazon H; Chauhan PS; Porquet F; Hoffmann GB; Accolla R; Willems L
    Blood Adv; 2020 Nov; 4(21):5574-5579. PubMed ID: 33170933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of HTLV-1 HBZ post-translational modifications.
    Dissinger N; Shkriabai N; Hess S; Al-Saleem J; Kvaratskhelia M; Green PL
    PLoS One; 2014; 9(11):e112762. PubMed ID: 25389759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo.
    Miyazato P; Matsuoka M
    Int Immunol; 2014 Aug; 26(8):419-25. PubMed ID: 24792037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
    Casseb J
    Clin Infect Dis; 1998 Nov; 27(5):1309-10. PubMed ID: 9827287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.